Barcelona, Spain

Monica Alonso-Xalma

This inventor holds 5 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Esteve Pharmaceuticals, S.a., Laboratorios Del Dr. Esteve S.a.. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monica Alonso-Xalma. Retrieved from https://idiyas.com/inventor/monica-alonso-xalma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 20.0

 

 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Monica Alonso-Xalma

Introduction

Monica Alonso-Xalma is a prolific inventor based in Barcelona, Spain, known for her significant contributions to the field of medicinal chemistry. With five patents to her name, she has focused on developing novel compounds aimed at treating pain and pain-related conditions. Her work stands at the intersection of chemistry and pharmacology, proving essential for advances in therapeutic strategies.

Latest Patents

Monica’s latest patents showcase her innovative approach to addressing critical health issues. One notable invention involves quinoline and isoquinoline derivatives specifically designed for treating pain. This invention relates to new compounds demonstrating remarkable affinity and activity towards the alpha-2-delta subunit of voltage-gated calcium channels (VGCC), particularly the alpha-2-delta-1 subunit. These compounds hold promise in the development of pain management therapies by modulating calcium channels and the noradrenaline transporter (NET).

Another significant patent includes alkyl and aryl derivatives of 1-oxa-4,9-diazaspiro undecane compounds. These compounds exhibit dual pharmacological activity against both the sigma (σ) receptor and the mu-opioid receptor. Monica's research encompasses the preparation processes of these compounds, their pharmaceutical compositions, and their therapeutic applications, emphasizing their potential in pain treatment.

Career Highlights

Monica has laid a strong foundation in her career, having worked with Esteve Pharmaceuticals, S.A., and Laboratorios del Dr. Esteve, S.A. These experiences have equipped her with invaluable insights into pharmaceutical development and innovation, reinforcing her status as a leading inventor in her field.

Collaborations

Throughout her career, Monica has collaborated with skilled professionals, including Marina Virgili-Bernado and Carmen Almansa-Rosales. These collaborations have fostered a creative environment, sparking new ideas and enhancing the effectiveness of her research initiatives.

Conclusion

Monica Alonso-Xalma’s innovative spirit and dedication to improving pain management through her groundbreaking inventions make her a notable figure in the field of medicinal chemistry. Her patents not only reflect her expertise but also her commitment to advancing therapeutic options for patients, thus carving a path for future innovations in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…